TY - JOUR T1 - Expression of Constitutive Androstane Receptor Splice Variants in Human Tissues and Their Functional Consequences JF - Journal of Pharmacology and Experimental Therapeutics JO - J Pharmacol Exp Ther SP - 811 LP - 821 DO - 10.1124/jpet.104.069310 VL - 311 IS - 2 AU - Jatinder K. Lamba AU - Vishal Lamba AU - Kazuto Yasuda AU - Yvonne S. Lin AU - Mahfoud Assem AU - Emma Thompson AU - Stephen Strom AU - Erin Schuetz Y1 - 2004/11/01 UR - http://jpet.aspetjournals.org/content/311/2/811.abstract N2 - The constitutive androstane receptor (CAR) NR1I3 is a transcription factor that upon activation by xenobiotics induces transcription of drug-metabolizing and drug transporter genes. Our goal was to identify whether alternative splicing of CAR makes an important contribution to the generation of novel CAR proteins. The wild-type CAR mRNA (CAR.1) and splice variants (SVs) were amplified from human liver cDNAs and in a panel of cDNAs from 36 human tissues, using exon 1- and 3′-untranslated region primers, cloned and sequenced. Twenty-two unique hCAR splice variants (CAR-SVs) containing different combinations of splicing (deletion of exons 2, 4, 5, 7, partial deletion of exon 9, or insertion of 12 or 15 base pairs from introns 6 or 7) were identified. CAR mRNAs were expressed in small intestine, kidney, testis, adrenal, and brain caudate nucleus. Intestine expressed only CAR.1 mRNA, whereas spleen, heart, and prostate expressed only CAR-SVs. In vitro transcription and translation of CAR-SVs lacking exon 2 (missing ATG start site) generated CAR proteins that differed in Mr from CAR.1. These CAR-SVs used a translation initiation site in exon 1, generating CAR with a unique amino-terminal sequence. Transcripts lacking part of exon 9 altered the CAR reading frame generating CAR proteins with a unique carboxy-terminal end. CAR-SVs demonstrated compromised binding to CYP2B6 NR elements and transcriptional activation of a CYP2B6 luciferase reporter. The expression of CAR in additional human cell types increases the range of tissue specific transcriptional responses regulated by this receptor, suggesting additional biological roles for CAR and CAR-SV proteins in these tissues. The American Society for Pharmacology and Experimental Therapeutics ER -